Early predictive value of 18F-FDG-PET assessment in advanced esophagogastric junction and gastric cancer patients treated with cetuximab-containing therapy

被引：0
|
作者：
Di Fabio, F.
Pinto, C.
Llimpe, F. Rojas
Castellucci, P.
Fanti, S.
Mutri, V.
Giaquinta, S.
Di Tullio, P.
Pini, S.
Compagnone, G.
Martoni, A.
机构：
[1] St Orsola Marcello Malpighi Hosp, Med Oncol Unit, Bologna, Italy
[2] St Orsola Marcello Malpighi Hosp, Nucl Med Unit, Bologna, Italy
[3] St Orsola Marcello Malpighi Hosp, Med Phys Unit, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15601
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EVALUATION OF EARLY PREDICTIVE 18F-FDG-PET ASSESSMENT IN ADVANCED ESOPHAGOGASTRIC JUNCTION AND GASTRIC CANCER PATIENTS TREATED WITH CETUXIMAB-CONTAINING THERAPY
    Di Fabio, F.
    Pinto, C.
    Limpe, Rojas F.
    Castellucci, P.
    Fanti, S.
    Mutri, V
    Giaquinta, S.
    Di Tullio, P.
    Pini, S.
    Compagnone, G.
    Martoni, A.
    ANNALS OF ONCOLOGY, 2009, 20 : 26 - 26
  • [2] The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab
    Di Fabio, Francesca
    Pinto, Carmine
    Rojas Llimpe, Fabiola L.
    Fanti, Stefano
    Castellucci, Paolo
    Longobardi, Ciro
    Mutri, Vita
    Funaioli, Chiara
    Sperandi, Francesca
    Giaquinta, Stefania
    Martoni, Andrea A.
    GASTRIC CANCER, 2007, 10 (04) : 221 - 227
  • [3] The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab
    Francesca Di Fabio
    Carmine Pinto
    Fabiola L. Rojas Llimpe
    Stefano Fanti
    Paolo Castellucci
    Ciro Longobardi
    Vita Mutri
    Chiara Funaioli
    Francesca Sperandi
    Stefania Giaquinta
    Andrea A. Martoni
    Gastric Cancer, 2007, 10 : 221 - 227
  • [4] The predictive role of 18F-FDG-PET early evaluation in patients treated with cetuximab plus chemotherapy for advanced gastric or gastroesophageal adenocarcinoma
    Di Fabio, Francesca
    Pinto, Carmine
    Llimpe, Fabiola Lorena Rojas
    Fanti, Stefano
    Castellucci, Paolo
    Longobardi, Ciro
    Mutri, Vita
    Funaioli, Chiara
    Giaquinta, Stefania
    Martoni, Andrea Angelo
    ANNALS OF ONCOLOGY, 2007, 18 : 21 - 21
  • [5] Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
    Skougaard, Kristin
    Nielsen, Dorte
    Jensen, Benny Vittrup
    Pfeiffer, Per
    Hendel, Helle Westergren
    ACTA ONCOLOGICA, 2016, 55 (9-10) : 1175 - 1182
  • [6] Predictive value of TILs in evaluation of 18F-FDG-PET in breast cancer
    Hirakata, Tomoko
    Takaaki, Fujii
    Kurozumi, Sasagu
    Katayama, Chika
    Yajima, Reina
    Obayashi, Sayaka
    Nakazawa, Yuko
    Tokuda, Naoko
    Yanai, Keiko
    Honda, Chikako
    Kuwano, Hiroyuki
    CANCER RESEARCH, 2018, 78 (04)
  • [7] Predictive Value of 18F-FDG-PET/CT in Locally Advanced Cervical Carcinoma Treated with Neoadjuvant Chemotherapy
    Ippolito, M.
    Cosentino, S.
    Sara, B.
    Gabriella, M.
    Franco, M.
    Scibilia, G.
    Banna, G.
    Fraggetta, F.
    Parisi, A.
    Lipari, H.
    Scollo, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S495 - S495
  • [8] Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy
    Kim, Nalee
    Kim, Jin Sung
    Geol Lee, Chang
    PLOS ONE, 2020, 15 (07):
  • [9] 18F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
    Ahmaddy, Freba
    Burgard, Caroline
    Beyer, Leonie
    Koehler, Viktoria Florentine
    Bartenstein, Peter
    Fabritius, Matthias P.
    Geyer, Thomas
    Wenter, Vera
    Ilhan, Harun
    Spitzweg, Christine
    Todica, Andrei
    CANCERS, 2021, 13 (02) : 1 - 13
  • [10] Exploring the predictive value of early 18F-FDG pet evaluation during treatment with cetuximab plus chamotherapy for advanced gastric or gastroesophageal adenocarcinoma
    Di Fabio, F.
    Pinto, C.
    Rojas, Llimpe F.
    Fanti, S.
    Castellucci, P.
    Longobardi, C.
    Mutri, V
    Funaioli, C.
    Giaquinta, S.
    Martoni, A.
    ANNALS OF ONCOLOGY, 2007, 18 : VII92 - VII92
12345